Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
X. Pintó, P. Valdivielso, J.M. Perez de Juan, N. Plana, C. Garcia-Arias, F.J. Fuentes, A. Hernández-Mijares & J.M. Mostaza. (2014) Predictive factors of achieving therapeutic goals of hypertriglyceridemia. Current Medical Research and Opinion 30:1, pages 19-26.
Read now
Read now
William S. Harris, Thomas D. Dayspring & Terrance J. Moran. (2013) Omega-3 Fatty Acids and Cardiovascular Disease: New Developments and Applications. Postgraduate Medicine 125:6, pages 100-113.
Read now
Read now
Julicristie M. Oliveira & Patrícia H.C. Rondó. (2011) Omega-3 Fatty Acids and Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy: Systematic Review and Meta-analysis. HIV Clinical Trials 12:5, pages 268-274.
Read now
Read now
DJ Blom. (2010) Hypertriglyceridaemia: Aetiology, Complications and Management. Journal of Endocrinology, Metabolism and Diabetes of South Africa 15:1, pages 11-17.
Read now
Read now
DJ Blom. (2010) Hypertriglyceridaemia: Aetiology, complications and management. South African Family Practice 52:2, pages 107-113.
Read now
Read now
Harold E. Bays, Kevin C. Maki, Ralph T. Doyle & Evan Stein. (2009) The Effect of Prescription Omega-3 Fatty Acids on Body Weight after 8 to 16 Weeks of Treatment for Very High Triglyceride Levels. Postgraduate Medicine 121:5, pages 145-150.
Read now
Read now
Articles from other publishers (15)
Louise Weiwei Lu, Siew-Young Quek, Shi-Ping Lu & Jie-Hua Chen. (2023) Potential Benefits of Omega-3 Polyunsaturated Fatty Acids (N3PUFAs) on Cardiovascular Health Associated with COVID-19: An Update for 2023. Metabolites 13:5, pages 630.
Crossref
Crossref
Harshani Nadeeshani, Niranjan Rajapakse & Se‐Kwon Kim. 2020. Encyclopedia of Marine Biotechnology. Encyclopedia of Marine Biotechnology
3041
3084
.
Montserrat Cofán & Emilio Ros. (2019) Use of Plant Sterol and Stanol Fortified Foods in Clinical Practice. Current Medicinal Chemistry 26:37, pages 6691-6703.
Crossref
Crossref
Ann C. Skulas-Ray, Peter W.F. Wilson, William S. Harris, Eliot A. Brinton, Penny M. Kris-Etherton, Chesney K. Richter, Terry A. Jacobson, Mary B. Engler, Michael Miller, Jennifer G. Robinson, Conrad B. Blum, Delfin Rodriguez-Leyva, Sarah D. de Ferranti & Francine K. Welty. (2019) Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association. Circulation 140:12.
Crossref
Crossref
Nilufar Mossaheb, Konstantinos Papageorgiou, Miriam R. Schäfer, Jana Becker, Monika Schloegelhofer & G. Paul Amminger. (2018) Changes in triglyceride levels in ultra-high risk for psychosis individuals treated with omega-3 fatty acids. Early Intervention in Psychiatry 12:1, pages 30-36.
Crossref
Crossref
S. Marlene Grenon, Christopher D. Owens, Emily V. Nosova, Millie Hughes‐Fulford, Hugh F. Alley, Karen Chong, Sandra Perez, Priscilla K. Yen, John Boscardin, Jason Hellmann, Matthew Spite & Michael S. Conte. (2015) Short‐Term, High‐Dose Fish Oil Supplementation Increases the Production of Omega‐3 Fatty Acid–Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA‐PAD I Trial). Journal of the American Heart Association 4:8.
Crossref
Crossref
Mark J. GrahamRichard G. LeeThomas A. BellIIIIIIWuxia FuAdam E. MullickVeronica J. AlexanderWalter SingletonNick VineyRichard GearyJohn SuBrenda F. BakerJennifer BurkeyStanley T. CrookeRosanne M. Crooke. (2013) Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans. Circulation Research 112:11, pages 1479-1490.
Crossref
Crossref
Charles J Glueck, Naseer Khan, Muhammad Riaz, Jagjit Padda, Zia Khan & Ping Wang. (2012) Titrating lovaza from 4 to 8 to 12 grams/day in patients with primary hypertriglyceridemia who had triglyceride levels >500 mg/dl despite conventional triglyceride lowering therapy. Lipids in Health and Disease 11:1.
Crossref
Crossref
J.J. Dalal, R.R. Kasliwal, A.L. Dutta, J.P.S. Sawhney, S.S. Iyengar, S. Dani, N. Desai, I. Sathyamurthy, D. Rao, A. Menon, A. Dasbiswas, G.S. Wander, M. Chadha, M.S. Hiremath, D.G. Roy, V. Gupta & N. Shivakadaksham. (2012) Role of omega-3 ethyl ester concentrate in reducing sudden cardiac death following myocardial infarction and in management of hypertriglyceridemia: An Indian consensus statement. Indian Heart Journal 64:5, pages 503-507.
Crossref
Crossref
Yan FengHao XuKeji Chen. (2012)
Natural Polypill
Xuezhikang
: Its Clinical Benefit and Potential Multicomponent Synergistic Mechanisms of Action in Cardiovascular Disease and Other Chronic Conditions
. The Journal of Alternative and Complementary Medicine 18:4, pages 318-328.
Crossref
Crossref
S Marlene Grenon, Millie Hughes-Fulford, Joseph Rapp & Michael S Conte. (2012) Polyunsaturated fatty acids and peripheral artery disease. Vascular Medicine 17:1, pages 51-63.
Crossref
Crossref
Hildegunn Aarsetoey, Heidi Grundt, Ottar Nygaard & Dennis W. T. Nilsen. (2012) The Role of Long-Chained Marine N-3 Polyunsaturated Fatty Acids in Cardiovascular Disease. Cardiology Research and Practice 2012, pages 1-15.
Crossref
Crossref
Raffaele De Caterina. (2011) n–3 Fatty Acids in Cardiovascular Disease. New England Journal of Medicine 364:25, pages 2439-2450.
Crossref
Crossref
Janet Zand, Frank Lanza, Harsha K. Garg & Nathan S. Bryan. (2011) All-natural nitrite and nitrate containing dietary supplement promotes nitric oxide production and reduces triglycerides in humans. Nutrition Research 31:4, pages 262-269.
Crossref
Crossref
Michelle L. GriffithBipin N. Savani & Jeffrey B. Boord. (2010) Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management. Blood 116:8, pages 1197-1204.
Crossref
Crossref